Kerecis participated in the Melanoma Research Alliance – Scientific Retreat this week. With rapidly improving survival rates, new cancer treatments lead to high risk of wound dehiscence and graft failure. Kerecis Omega3 rich fish skin decreases postsurgical complications and improves outcomes
To read more about the event visit there page: https://www.curemelanoma.org/
From the town of Ísafjörður in northwest Iceland, Kerecis develops, manufactures, and distributes patented fish-skin medical devices that support soft tissue regeneration in the body, with regulatory approvals in the United States, Europe, and beyond.
